Oct 26, 2016 by Brian FeroldiIllumina, Inc. in 3 ChartsThese three graphics show investors what they need to know about the genetic testing company.
Oct 26, 2016 by Brian FeroldiCullen/Frost Bankers Turns the CornerA steep decline in loan loss provisions allows the regional bank to return to profitable growth.
Oct 26, 2016 by Brian Feroldi3 Lowest-P/E Stocks TodayThese three companies are "cheap," but is any actually worth owning?
Oct 26, 2016 by Brian FeroldiHere's Why Exact Sciences Corporation's Stock Is Dropping TodayShares plunge after management reins in its full-year revenue guidance range after reporting a blowout quarter.
Oct 26, 2016 by Brian FeroldiIn Your 50s? 2 Stocks You Should Consider BuyingBoth of these companies have proven business models, strong growth prospects, and respectable dividend payouts.
Oct 25, 2016 by Brian FeroldiWhy Global Blood Therapeutics Inc.'s Shares Are Soaring TodayThe stock jumps after the company announced that it has reached an agreement with the FDA on the trial design for its upcoming phase 3 HOPE study.
Oct 24, 2016 by Brian FeroldiWhy Inovio Pharmaceuticals Inc. Is Dropping TodayShares plunge after the FDA places the company's lead compound on clinical hold.
Oct 19, 2016 by Brian Feroldi, Sean Williams, and Tyler CroweWant to Own a Legal Monopoly? Then You'll Love These 3 StocksBelieve it or not, monopolies still exist. Here's how investors can benefit.
Oct 18, 2016 by Brian Feroldi3 Stocks I'm Never SellingGrowth potential, deep moats, thriving business models are among the reasons I can't see myself ever parting ways with these three companies' shares.
Oct 18, 2016 by Brian FeroldiWhy Abeona Therapeutics Inc. Is Surging TodayShares rally in response to the news that the European Union has granted orphan-drug designation to one of the company's compounds.
Oct 18, 2016 by Brian FeroldiHate Checking Your Portfolio? Try These 2 StocksLooking for sleep-well-at-night stocks? Give these two companies a closer look.
Oct 17, 2016 by Brian FeroldiWhy PTC Therapeutics, Inc. Is Crashing TodayShares tank after the company provided investors with regulatory updates related to its DMD drug, Translarna.
Oct 17, 2016 by Brian Feroldi, Selena Maranjian, and Todd CampbellWhat's the Right Number of Stocks to Own in Your Portfolio?Here's how our team of Foolish contributors answers this age-old question.
Oct 17, 2016 by Brian Feroldi, Jason Hall, and Matt Frankel, CFP3 ETFs to Keep You Invested After RetirementHere are three funds that our contributors think are ideal for investors in their golden years.
Oct 16, 2016 by Brian Feroldi, Dan Caplinger, and Jason HallJust How Much Money Do You Really Need for Retirement?This is a tricky question to tackle, but our team of contributors offers up some advice for how to approach an answer.
Oct 15, 2016 by Brian FeroldiThese 3 Stocks Are Up Over 500% Over the Last 10 YearsGreat stocks can continue to rise for years on end, so should investors consider buying shares of these three stellar performers today?
Oct 14, 2016 by Brian FeroldiMy 3 Biggest Stock HoldingsAnd the three key lessons that I've learned from owning them.
Oct 14, 2016 by Brian Feroldi, Sean Williams, and Jason Hall3 Smart Ways to Rid Yourself of DebtAre you buried in debt? Here are three methods you can use pull yourself out of the hole.
Oct 13, 2016 by Brian FeroldiWhy TG Therapeutics, Inc. Stock Is Dropping TodayShares fell after management announced a few changes to one of its late-stage clinical trials.
Oct 13, 2016 by Brian Feroldi, Jason Hall, and Matt Frankel, CFP3 Surprising Habits of Smart InvestorsWant better investment returns? Here are three habits that the smartest investors use to get the job done.
